This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
Page 2 of 3

Exxon or Chevron? Both Seem Reasonable

By Chuck Carnevale

Chevron seems to be a slightly more attractive investment, but that's not to say Exxon isn't worth another look.

01:11PM 09/06/13

Nike: Good Company vs.Good Investment

By Chuck Carnevale

Its business results don't appear to be a problem, but Nike's valuation moving forward might be.

12:36PM 08/29/13

Today's Earnings Valued Attractively (Teva)

By Chuck Carnevale

Israel-based Teva doesn't have to do anything spectacular to warrant a second look.

10:19AM 08/16/13

Walgreen Is Terrific, After That CVS

By Chuck Carnevale

Chuck Carnevale differs from Jim Cramer in his comparison of the two giants of the pharmacy services industry.

01:18PM 08/07/13

Amazon's Amazing Stock Levitation Trick

By Chuck Carnevale

These 12 charts reveal why Amazon is really amazing and befuddling at the same time.

11:05AM 07/22/13

Starbucks' High Should Keep You Awake at Night

By Chuck Carnevale

Starbucks is a great company at a lousy price.

04:51PM 06/21/13

A Good Stock Is 'Deere' Today

By Chuck Carnevale

Nothing runs like the machinery maker when times are good.

11:02AM 05/24/13

Is Cisco a Growth Stock or a Dividend Stock?

By Chuck Carnevale

Here's what's behind the rise in Cisco stock.

12:30PM 05/16/13

Riding Norfolk Southern to Value

By Chuck Carnevale

Norfolk Southern is an above-average dividend growth stock that is currently attractively valued.

01:29PM 04/25/13

Stryker: A Dividend Growth Stock Value Idea

By Chuck Carnevale

Health care is one sector where you can still find a bargain, like Stryker.

10:56AM 04/05/13

Page 2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,126.12 -36.87 -0.20%
S&P 500 2,120.79 -2.69 -0.13%
NASDAQ 5,097.9760 -8.6170 -0.17%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs